Metraipolis › archive › dc_08b3f494ec32
Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed… — Europe PMC PMID:41904478
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41904478
- DOI
- 10.1186/s13287-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T17:34:52.718Z
- SHA-256 of the archived text
b2eb7aca2f24d07a54b79cf7c4654dd93ffbc9e206b4eae4e2500f922679a7df- Stable URL of this page
https://metraipolis.com/documento/dc_08b3f494ec32
How to cite
Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed… — Europe PMC PMID:41904478 — Europe PMC (en), https://europepmc.org/article/MED/41904478 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08b3f494ec32 (Metraipolis archive dc_08b3f494ec32, sha256 b2eb7aca2f24d07a54b79cf7c4654dd93ffbc9e206b4eae4e2500f922679a7df)
BibTeX
@misc{dc08b3f494ec32,
title = {Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed… — Europe PMC PMID:41904478},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41904478},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08b3f494ec32; sha256 b2eb7aca2f24d07a54b79cf7c4654dd93ffbc9e206b4eae4e2500f922679a7df},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41904478. Agents can read the archived copy with the MCP tool read_document.